Bentham Science Logo

Current Drug Discovery Technologies

Volume 17, 5 Issues, 2020
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
Order Your Article Before Print

Track Your Manuscript:


In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research

Contents

Current Drug Discovery Technologies, Volume 13 - Number 2



Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

, 13(2): 68 - 76

Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall and John Abisheganaden


DOI: 10.2174/1570163813666160524142846







Editor-in-Chief

Vladimir P. Torchilin
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
(USA)

Biography View Full Editorial Board

Journal History

Current Drug Discovery Technologies Journal was launched in 2004. Dr. Vladimir P. Torchilin serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.42

New eBook

Frontiers in Clinical Drug Research – Alzheimer Disorders



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

Webinars for Bentham Authors

Related Journals

Related eBooks

eBooks Catalog